XML 54 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Share-based Compensation - Summary of Nonvested Share Awards Activity (Detail) - $ / shares
9 Months Ended
Oct. 03, 2021
Sep. 27, 2020
Nonvested Share Awards [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Nonvested shares/share units, beginning balance 591,325  
Granted, shares/share units 248,550 321,600
Vested, shares/share units (268,550)  
Forfeited, shares/share units (15,655)  
Nonvested shares/share units, ending balance 555,670  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Weighted-Average Grant-Date Fair Value, Beginning Balance $ 3.79  
Weighted-Average Grant-Date Fair Value, Granted 15.61 $ 1.69
Weighted-Average Grant-Date Fair Value, Vested 4.83  
Weighted-Average Grant-Date Fair Value, Forfeited 6.16  
Weighted-Average Grant-Date Fair Value, Ending Balance $ 8.51  
Nonvested Share Unit Awards [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Nonvested shares/share units, beginning balance 41,160  
Granted, shares/share units 2,614  
Dividend reinvestments, shares/share units 14,841  
Vested, shares/share units (40,000)  
Dividend reinvestments vested, shares/share units (15,975)  
Nonvested shares/share units, ending balance 2,640  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Weighted-Average Grant-Date Fair Value, Beginning Balance $ 1.91  
Weighted-Average Grant-Date Fair Value, Granted 28.69  
Weighted-Average Grant-Date Fair Value, Dividend Reinvestments 27.46  
Weighted-Average Grant-Date Fair Value, Vested 2.28  
Weighted-Average Grant-Date Fair Value, Dividend Reinvestments Vested 25.98  
Weighted-Average Grant-Date Fair Value, Ending Balance $ 20.86